TrialJournal of neuro-oncology2013

O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.

Xiaoyin Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.